Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02100579 · ClinicalTrials.gov registry record · Phase 4
Ultrasound-guided Adductor Canal Block for Total Knee Replacement
A Phase 4 study, sponsored by Northwestern University.
- Completed
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
NCT02100579 is a Phase 4 study that has completed, run by Northwestern University. The registered enrollment target is 40 participants.
The verdict
NCT02100579, a Phase 4 study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
Study Summary
Total knee arthroplasty is associated with intense early postoperative pain. Fast track recovery programs including early therapy protocols and early hospital discharge are being implemented at various hospitals. The postoperative analgesic pain regimen should enhance functional recovery in addition to providing efficient analgesia with minimal side effects. Adductor canal blockade is commonly used to provide postoperative analgesia for total knee arthroplasty (TKA) surgery. The investigators hypothesize that an ultrasound guided adductor canal block will lower narcotic consumption and improved overall satisfaction compared to ultrasound guided sham block with normal saline (placebo) for patients undergoing minimally invasive TKA surgery.
Interventions
- DRUG Bupivacaine
- DRUG Preservative free normal saline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2014-03 |
| Est. Completion | 2015-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02100579
The ClinicalTrials.gov registry entry for NCT02100579 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Bupivacaine is the first listed.
NCT02100579 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02100579 about?
NCT02100579 is a clinical study titled "Ultrasound-guided Adductor Canal Block for Total Knee Replacement". Total knee arthroplasty is associated with intense early postoperative pain. Fast track recovery programs including early therapy protocols and early hospital discharge are being implemented at various hospitals. The postoperative analgesic pain regimen should enhance functional recovery in addition...
What is the current status of trial NCT02100579?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2014-03. Estimated completion is 2015-12.
What interventions are being tested in trial NCT02100579?
The interventions under investigation include: Bupivacaine (DRUG), Preservative free normal saline (DRUG).
Who is sponsoring clinical trial NCT02100579?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.